Literature DB >> 8885795

Cytopathology of false negatives preceding cervical carcinoma.

R M DeMay1.   

Abstract

The Papanicolaou smear has been a remarkably effective tool in cancer prevention, but it is not a perfect test. Although the most important factor in failure of cervical cancer prevention is lack of adequate screening, other factors include problems with sampling, interpretation, and effective clinical follow-up. A small number of rapidly developing cervical cancers probably also arise in the interval between Papanicolaou smear screenings. Consequently, cervical cancer will develop in some women despite appropriate screening. This article will analyze some of the problems relating to diagnostic errors, which include abnormal cells that are few (< 100), small, or bland.

Entities:  

Mesh:

Year:  1996        PMID: 8885795     DOI: 10.1016/s0002-9378(96)70013-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  False Negative Results in Cervical Cancer Screening-Risks, Reasons and Implications for Clinical Practice and Public Health.

Authors:  Anna Macios; Andrzej Nowakowski
Journal:  Diagnostics (Basel)       Date:  2022-06-20

Review 2.  Mesoscale imaging with cryo-light and X-rays: Larger than molecular machines, smaller than a cell.

Authors:  Axel A Ekman; Jian-Hua Chen; Jessica Guo; Gerry McDermott; Mark A Le Gros; Carolyn A Larabell
Journal:  Biol Cell       Date:  2016-11-14       Impact factor: 4.458

3.  Cytologic changes of ovarian epithelial cancer induced by neoadjuvant chemotherapy.

Authors:  Yiying Wang; Yue Wang; Wenxin Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

4.  PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy.

Authors:  Yue Wang; Yiying Wang; Jie Li; Zeng Yuan; Bingbing Yuan; Tingguo Zhang; Janiel M Cragun; Beihua Kong; Wenxin Zheng
Journal:  J Hematol Oncol       Date:  2013-08-19       Impact factor: 17.388

5.  Biomarkers in cervical cancer.

Authors:  Eun-Kyoung Yim; Jong-Sup Park
Journal:  Biomark Insights       Date:  2007-02-07

6.  Cervical Cancer in Women with Normal Papanicolaou Tests: A Korean Nationwide Cohort Study.

Authors:  Miseon Kim; Hyeongsu Kim; Dong Hoon Suh; Yong Beom Kim
Journal:  Cancer Res Treat       Date:  2020-12-10       Impact factor: 4.679

7.  A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics.

Authors:  Kristin Lm Boylan; Somaieh Afiuni-Zadeh; Melissa A Geller; Kayla Hickey; Timothy J Griffin; Stefan E Pambuccian; Amy Pn Skubitz
Journal:  Clin Proteomics       Date:  2014-07-14       Impact factor: 3.988

8.  Morphometric Analysis of Thyroid Follicular Cells with Atypia of Undetermined Significance.

Authors:  Youngjin Kang; Yoo Jin Lee; Jiyoon Jung; Youngseok Lee; Nam Hee Won; Yang Seok Chae
Journal:  J Pathol Transl Med       Date:  2016-06-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.